Skip to main content
Veterinary Medicines

Kaltetan forte, 458.4 mg/ml + 125 mg/ml + 20 mg/ml solution for infusion for horses, cattle and pigs

Authorised
  • CALCIUM GLUCONATE FOR INJECTION
  • Magnesium chloride hexahydrate
  • Sodium glycerophosphate pentahydrate

Identifikazzjoni tal-prodott

Isem tal-mediċina:
Kaltetan forte, 458.4 mg/ml + 125 mg/ml + 20 mg/ml solution for infusion for horses, cattle and pigs
Kaltetan forte, 458,4 mg/ml + 125 mg/ml + 20 mg/ml, infuzinis tirpalas arkliams, galvijams ir kiaulėms
Sustanza attiva:
Metodu ta’ amministrazzjoni:
  • Użu għal ġol-vini

Dettalji tal-prodott

Sustanza attiva / Qawwa:
  • Disponibbli biss fi English
    458.40
    milligram(s)
    /
    1.00
    millilitre(s)
  • Disponibbli biss fi English
    125.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Disponibbli biss fi English
    20.00
    milligram(s)
    /
    1.00
    millilitre(s)
Forma farmaċewtika:
  • Soluzzjoni għall-infużjoni
Withdrawal period by route of administration:
  • Intravenous use
    • Horse
      • Milk
        5
        week
    • Cattle
      • Meat and offal
        5
        week
    • Pig
      • Meat and offal
        5
        week
Kodiċi veterinarju anatomiku terapewtiku kimiku (ATCvet):
  • QA12AX
Status tal-awtorizzazzjoni:
  • Valid
Authorised in:
  • Lithuania
Available in:
  • Lithuania
Deskrizzjoni tal-pakkett:

Tagħrif addizzjonali

Entitlement type:
Id-detentur tal-awtorizzazzjoni għat-tqegħid fis-suq:
  • Vet-Agro Multi-Trade Company Sp. z o.o.
Marketing authorisation date:
Siti ta’ manifattura b’rilaxx tal-lott:
  • Multi-Trade Company "Vet-Agro" Sp. z o.o.
Awtorità responsabbli:
  • State Food And Veterinary Service
Numru tal-awtorizzazzjoni:
  • LT/2/22/2697/001
Data tal-bidla fl-istatus tal-awtorizzazzjoni:
Numru tal-proċedura:
  • PL/V/0110/002

Dokumenti

RV2697.pdf

Lithuanian (PDF)
Ippubblikat fuq: 25/07/2022
Niżżel
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."